SEMA3D and breast carcinoma: Recent research showed that SEMA3D which encodes a member of the semaphorin III family of secreted signaling proteins that are involved in axon guidance during neuronal development has a certain correlation with the development of breast cancer, glioblastoma, pancreatic cancer, thyroid cancer, and other tumors [4–8].